Linn Energy LLC (LINE) has been named as a Top 10 dividend paying energy stock, according to Dividend Channel, which published its weekly ''DividendRank'' report. The report noted that among energy companies, LINE shares displayed both attractive valuation metrics and strong profitability metrics. For example, the recent LINE share price of $30.27 represents a price-to-book ratio of 1.8 and an annual dividend yield of 9.58% — by comparison, the average energy stock in Dividend Channel's coverage universe yields 4.9% and trades at a price-to-book ratio of 2.6. The report also cited the strong monthly dividend history at Linn Energy LLC, and favorable long-term multi-year growth rates in key fundamental data points.The report stated, '' Dividend investors approaching investing from a value standpoint are generally most interested in researching the strongest most profitable companies, that also happen to be trading at an attractive valuation. That's what we aim to find using our proprietary DividendRank formula, which ranks the coverage universe based upon our various criteria for both profitability and valuation, to generate a list of the top most 'interesting' stocks, meant for investors as a source of ideas that merit further research.'' The annualized dividend paid by Linn Energy LLC is $2.8992/share, currently paid in monthly installments, and its most recent dividend ex-date was on 12/10/2013. Below is a long-term dividend history chart for LINE, which Dividend Channel stressed as being of key importance. Indeed, studying a company's past dividend history can be of good help in judging whether the most recent dividend is likely to continue.
More from Stocks
Striking Options: Oil Prices Give Up Gains Amid U.S.-China Trade Uncertainty
Global oil supply growth is expected to surge in 2020.
Twitter Could Tumble If Key Support Finally Breaks
The risk exists that the social media giant's shares could gap sharply lower based on its charts.
Medtronic Rises After Posting Second-Quarter Earnings Beat
Medtronic rises after the medical equipment maker beat Wall Street's second-quarter earnings expectations.